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Abst rac t - -An  analysis of a parabolic partial differential equation modelling capillary network 
formation is presented. The model includes terms representing cell random motility, chemotaxis, 
and haptotaxis due to the presence of chemical stimuli: tumour angiogenic factors and fibronectin. 
The analysis provides an underlying insight into mechanisms ofcell migration which are crucial for 
tumour angiogenesis. Specific 1 and 2D examples are discussed in detail. (~) 1999 Elsevier Science 
Ltd. All rights reserved. 
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1. INTRODUCTION 
Angiogenesis (the formation of a capillary network of blood vessels from a pre-existing vascu- 
lature) is essential for the growth and development of solid tumours. Without such a network 
the tumour remains in a dormant avascular state. To facilitate angiogenesis the tumour secretes 
chemicals, collectively known as Tumour Angiogenic Factors (TAF) which induce neighbouring 
Endothelial Cells (EC) to degrade their basal lamina and to migrate into the Extracellular Ma- 
trix (ECM) towards the tumour. The ECM acts as a barrier to EC migration and has to be 
overcome in order for vascularization to be achieved. It is a fibrous material consisting of inter- 
stitial tissue, collagen fibre, fibronectin fibrils, fibronectin, and other components. Fibronectin 
enhances EC adhesion to the matrix and is also produced by the EC. Therefore, as well as moving 
in response to the chemical attractant TAF, EC migration is also regulated by the haptotactic 
effect of fibronectin (see [1] and the extensive references therein). Under these circumstances, 
the EC form capillary sprouts which continue to grow, branch, and form loops (anastomoses) 
through which blood eventually circulates. The branching increases dramatically as the tumour 
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is approached. If EC mitosis is prevented the growth of capillaries is drastically reduced and 
results only in a restricted network being formed that never reaches the tumour [2]. Experi- 
mental results also show that disrupting fibronectin-specific receptors on EC can lead to failed 
vascularization [3]. 
In [4], Anderson and Chaplain discuss a possible mechanism to explain why capillary sprouts 
cease migrating towards the tumour in the absence of mitosis. In this paper, we provide a detailed 
analysis of the model providing a deeper understanding of the mechanisms involved. 
2. THE MATHEMATICAL  MODEL 
In the absence of mitosis, the equation describing EC migration from [4] is, 
0---[ = DAn - div (X(c)n grad c) - p0div (n grad f ) ,  (1) 
where n(x, t) is the EC density, D is the cell random motility coefficient, X(c) is the chemotactic 
function (a measure of the sensitivity of EC receptors to TAF, c), f is the concentration of an ad- 
hesive chemical such as fibronectin, and P0 is the (constant) haptotactic oefficient. Equation (1) 
is normally posed in a bounded domain ft with no-flux boundary conditions on 0f~, and is similar 
to the classic Keller-Segel-type model [5]. In [4], the analysis is restricted to one-space dimension 
in which ft = [0, 1] and c(x, t), f(x, t) are assumed to be in quasi-steady state. In this case, (1) 
becomes On _02n O( De) O(~x) 
where c and f depend on x only. Furthermore, it is assumed in [4] that the chemotactic func- 
tion X(c) takes the form 
Xo (3) X(c) = 1 + ac' 
where X0 represents the maximum chemotactic response and a is a measure of the severity of 
desensitisation of EC receptors to TAF. A more detailed investigation of the problem in two- 
space dimensions with explicit time-dependent equations for the two chemical species (TAF, 
fibronectin) can be found in [6]. 
3. MODEL ANALYSIS AND SOLUTION 
To begin with, we write (2) in the more general form 
On-DO---IOn-nil(x)] 
O--7- Ox ~ 
(4) 
where H(x) D oc = (X(C)/)57 + (P(f)/D)-~x, (i.e., we make no particular assumptions regarding 
the chemotactic function X(c) and the haptotactic function p(f)), subject to no-flux boundary 
conditions and initial conditions, 
an 
Ox nil(x) = O, at x = 0, 1, n(x, O) = no(x) >_ O. (5) 
We first of all remark that since no(x) is nonnegative, it follows from the strong maximum 
principle [7], that n(x,t) is nonnegative for all t > 0. Let us now solve (4) using separation of 
variables by setting n(x, t) = T(t)N(x) to obtain 
d Dd[  d N-NH(x) ]+AN- -O.  (6) ~ T + AT =O, dx -~x 
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From (6) it is clear that T(t) is of the form exp(-At). If in (6) we make the substitution N = CY, 
where ¢ = exp(fo H(z) dz), then we arrive at the classical Sturm-Liouville problem for Y, namely 
dx L dz J = ACY. (7) 
This problem has a complete orthonormal set of eigenfunctions Y~(x) in the weighted Hilbert 
space L~(0, 1) with eigenvalues Ai ordered as, 0 = A0 < A1 <:_ As _< . . . .  
The eigenfunctions of (6) are then given by Ni(x) = ¢(x)Yi(x). Corresponding to A0 = 0 we 
have 
which is precisely the steady state solution given in [4] if we specialise the choice of X(c) given 
by (3). That the Ai (i = 1,2, . . .  ) are positive follows in the standard way of multiplying (6) by 
Ni on [0, 1] and using the boundary condition in (5). It is also easy to see that 
/01 A~ Ni dx = O, 
showing that the eigenfunctions Ni(x) (i = 1, 2, . . .  ) have zero mean value. Again by standard 
expansion theory we know that the eigenfunctions form a complete orthonormal set in L~_: (0, 1). 
Thus we can write 
oo 
n(z, t) = AoYo(x) + E AiN~(x)e-~'t' (9) 
i=1 
where the coefficients are determined by setting t = 0 and using the orthogonal properties of the 
eigenfunctions. Notice that as t --+ ec, n(x, t) --* AoNo(x) in (9), which is precisely the steady 
state discussed in [4]. 
4. EXAMPLES 
As a first example, consider the case where X(c) = Xo, is a positive constant (i.e., a = 0 in (3)) 
and the TAF concentration is c(x) = mix  + 1 - ml,  with c(1) = 1 at the tumour, p(f)  = po 
a positive constant, and the fibronectin concentration is f (x)  = 1 - m2x, with f(0) = 1 at the 
blood vessel. This reflects the experimentally observed results of a decreasing fibronectin profile 
away from the parent vessel [8,9]. In this example, 
H(x) = Xo Po w 
--~m: - -~m2 - D 
and the associated eigenvalue problem becomes 
that is 
d N 
d2 N dN 
D-~-~-x2 - w-~- x + AN = 0, where D dN - Nco = 0 at x = 0,1. 
It is an easy matter to show that the eigenfunctions and eigenvalues for (11) are 
No(x) = exp (DX)  , 
O2 
Nm(x)---- exp (~-~x) 
(~)  = exp x 
aJ 
[cos(mrrx) + 2--D-~m Sin(mTrx) ] , 
1 + w~ 4mff-~-2D2 ) cos(mTrx + ~m), 
AO ---- 0, 
~2 
Am = "~ + m27r2 D 
(lO) 
(II) 
(12) 
(13) 
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where tan~m = - (w/2m~rD)  (m = 1,2,3. . . ) .  From the first two terms from (9) we may 
approximate n(x,  t) by, 
n(x , t ) -Aoexp  x +Alexp  ~--~x- ~--~+~r2D t cos(Trx+/31). (14) 
From (14) we deduce the important fact that if w -- xoml  -pom2 < 0, then the EC density n(x,  t) 
decays exponentially from the blood vessel (x = 0) to the tumour (x = 1). This is clearly achieved 
if ml/m2 < Po/Xo. In the extreme case, this will happen if m2 is large and/or when ml is small, 
implying a high concentration of fibronectin and/or a low concentration of TAF near x -- 0 [8,9], 
i.e., EC migration will be restricted. 
If a ~ 0 then with the same choice of c(x) and f (x )  problems (4),(5) can be solved in terms 
of confluent hypergeometric functions (see [10, p. 249]). However, due to the relative complexity 
of such functions, the expansion (9) is not particularly informative. Nevertheless, it is clear that 
desensitisation is related to lowering the chemotactic response and so the results above for a -- 0 
are enhanced for a ~ 0, as numerically demonstrated in [4]. 
Finally, we remark here that the second term in (14) shows that for w < 0, n(x , t )  has a 
wave-like component of the form 
exP~D[X- (2 -b2~r2f2) t ]cos (mzcx+/3m) ,  
which represents a wave with decaying amplitude, moving back towards the blood vessel (x = 0) 
with speed c = - (w/2  + 2(r2D2/w)) .  
To further illustrate the importance of haptotaxis in angiogenesis we consider a two-space 
dimensional example. Specifically, we consider (1) defined on the square region, ~ -- (x ,y  E 
[0, 1] x [0, 1]}, where the tumour occupies the region x -- 1, 0 <: y < 1, the parent blood vessel 
occupies the region x = 0, 0 <_ y < 1 and the regions y = 0, y = 1, 0 < x < 1 represent physical 
barriers. Thus along the boundary of the rectangular region we have the no-flux boundary 
conditions 
DOn 0c _~ 
Ox - X (c )n~x - p ( f )n  = O, for x --- 0, 1 and 0 < y < 1, 
(15) 
D °noy oc - X(c)n-~y - p ( f )n  = O, for 0 < x < 1 and y = 0, 1. 
As above we take the quasi-steady state fibronectin concentration to have the form, f(x) = 
1 - m2x,  rn2 _< 1, and the TAF concentration to have the form, c(x_) = 1 + mix  + m3y - (ml -{- 
m3), ml -b m3 _< 1, which might approximate the TAF gradient produced by a tumour centred 
on (1,1). Furthermore, we consider, as before, a -- 0 and p(f )  = Po. Note that the forms chosen 
for c and f are representative only and other choices can be made. 
The model problem then becomes 
On On On 
---[ = DAn - W-~x xom3~y,  (16) 
subject o (15) and n(x_, 0) = no(x) >_ 0, where _x. = (x, y). By employing separation of variables 
n(x,  t) = X(x )Y (y )T ( t ) ,  we see that for some separation constants A and #, 
and 
T(t)  = exp(-At), 
D d2 X dX  
- = o 
D d2y  dY  
- + - = o .  
(17) 
(18) 
(19) 
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Solving (18) subject o 
dX 
D---- - ~X = 0, x = 0, 1, (20) 
dx 
gives the same eigenvalue problem as the 1D case, resulting in the eigenfunctions and eigenvahms, 
Xo(x) = exp (DX) , 
Xm(x) =exp(~--~x) 1+ 
032)  
4m27r2D2 cos(mTr +/~m), 
#o = 0, 
o32 
#m = ~ + m 2 7r2 D , 
(21) 
where 03 and tim are as defined above. Setting f~ = A - # and solving (19) subject o 
DE dy xornaY = O, y = O, 1, (22) 
we obtain the following eigenfunctions and eigenvalues: 
Yo(y) = exp (xom3 ~ n0 = 0, 
\ D Y]' 
( [Xom3 ~ xsm3 ~ (17r + 3't) Yt(Y) = exp ~ y )  1 + 4/27r202 ) cos (23) 
where f~l = (x2m]/4D) + 127r2D and "/t = -(xom3/2brD). Since Am,l = f~t +/Zm we find 
2 2 
_ Xom__3 + 127r2D, Ao,o = 0, Ao,t - 4D 
2 2 
w 2 + Xom3 + (l 2 + m 2) 7r2D, 
Am,t = 4D 
w 2 
Am,o = ~ + m27r2 D, 
with l ,m = 0,1 ,2 , . . . ,  
(24) 
with the corresponding eigenfunctions 
60 Xom3 
No,o(z, y) = exp -Sx + - i f -y ) ,  
( No,l(x,y) = exp (-~xW + ---Dy)X°m3 ~ 1 + 4127r2D2 ~cos(/r + 7t), 
Nm,o(X, y) = exp ~--~x 1 + 4m~-~2D  cos(mTr + ~m), 
(wx+xom3y~ (1-~ 032 
4m~-~-r2D2)(l+ x2m2 ~cos(mTr+l~m)COs(lTr+'~t). Nmj(x,y)=exp \ ~-~ ] 4127r2D2 ] 
'25) 
These functions may now be used to write down the complete igenfunction series represen- 
tation for the EC density n(x, y, t). As in the 1D example, the steady state solution is easily 
obtained from the solution to (25),(26) by setting A = 0, since for large t the other terms decay 
to 0 (cf. (12),(24)). Therefore, as t -~ c~, 
n(x, y) ~ Ao exp (wx + xom3y~ 
2D ]" 
(26) 
Figure 1 shows a diagrammatic representation f the manner in which the sign of wx + Xom3y/ 
2D affects the steady state solution (26). If, as in the 1D case, we have w < 0, then the resulting 
steady state decays exponentially from the blood vessel to the tumour. Provided wx + Xom3y < 0 
(e.g., the solid line in Figure 1) no connection is made between the vasculature and the tumour, 
i.e., angiogenesis is not completed. However, i fwx+xom3y > 0 (e.g., the dashed line in Figure 1) 
then the steady state (26) predicts an exponential increase in EC density towards the tumour, 
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Vessel 
wx + Xom3y < 0 
o• 
•" 
• •••.'*•'"•••'•••••• ~"~" s ~ 
• " s 
.• 4, ~ 
o• d 
WX + Xomay > 0 
J s 
s f s d 
'I~mom~ 
x 
wx + xomay = 0 
Figure 1. The effect of the sign of wx + xorn3y on the steady state EC density. If 
wx + xom3y < 0 then EC do not reach the tumour, however, if wx + xom3y > 0 at 
least some EC will reach the tumour, and therefore, complete angiogenesis. Note, 
whether or not the line wx + xom3y = 0 lies to the left or the right of line y = x 
depends upon the magnitude of m3. 
i.e., angiogenesis completed. Ifw > 0 then there is always an exponential growth of EC towards 
the tumour, i.e., angiogenesis always completed. 
Of course, one should bear in mind that the analysis is based on particular choices of TAF 
and fibronectin concentration profiles. As in the 1D case, it is possible to write down a complete 
solution to the problem when c~ ~ 0 in terms of confluent hypergeometric functions. 
5. CONCLUSIONS AND DISCUSSION 
We have presented an analysis of a mathemat ica l  model  for capillary network formation in 
the absence of EC proliferation• As pointed out in [4] the model  is exper imental ly  verifiable and 
suggests an exper iment whereby sources of TAF and fibronectin are placed at opposite ends of 
a square test-chamber. The initial distribution of EC is placed at the fibronectin end and the 
resulting spat io-temporal  evolution of EC migration monitored. 
Quite general forms of quasi-steady state TAF and fibronectin profiles can be used in this 
analysis• We have i l lustrated the effects in specific 1 and 2D examples,  which emphasise the im- 
portance of the magnitude of the fibronectin and TAF concentration gradients in governing where 
and to what  extent the capillary network fills the domain• Subsequently, the interplay between 
the chemotact ic  and haptotact ic coefficients decides whether or not angiogenesis is completed.  
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